Interim results from a large multinational extension trial (Guardian TM2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A

S. Lentz; C. L. Kempton; D. Janic; A. Savic; M. H. Cerqueira; M. C. Ozelo; M. Recht; J. Oldenburg; A. Tiede; T. Suzuki; I Matytsina; N. Zeuthen; E. Santagostino

Interim results from a large multinational extension trial (Guardian TM2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A

S. Lentz, C. L. Kempton, D. Janic, A. Savic, M. H. Cerqueira, M. C. Ozelo, M. Recht, J. Oldenburg, A. Tiede, T. Suzuki, I Matytsina, N. Zeuthen, E. Santagostino

Material

ARTIGO

Idioma

Inglês

Direito de acesso

Fechado

Assuntos

Hemofilia A

Resumo

Autoria

Ozelo, Margareth Castro, 1970-

XXV Congress of the International Society on Thrombosis and Haemostasis

Sites

DOI: https://doi.org/10.1111/hae.12990

Texto completo: https://onlinelibrary.wiley.com/doi/abs/10.1111/jth.12993

Interim results from a large multinational extension trial (Guardian TM2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A

S. Lentz, C. L. Kempton, D. Janic, A. Savic, M. H. Cerqueira, M. C. Ozelo, M. Recht, J. Oldenburg, A. Tiede, T. Suzuki, I Matytsina, N. Zeuthen, E. Santagostino

Interim results from a large multinational extension trial (Guardian TM2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A

S. Lentz, C. L. Kempton, D. Janic, A. Savic, M. H. Cerqueira, M. C. Ozelo, M. Recht, J. Oldenburg, A. Tiede, T. Suzuki, I Matytsina, N. Zeuthen, E. Santagostino

Fontes

Journal of thrombosis and haemostasis Vol. 13, supl 2 (June, 2015), p. 842